Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.
| Website: | www.urologix.com |
| Email: | mhill@urologix.com |
| Main Phone: | +1 763 475-1400 |
| Address: | 14405 21st Avenue North |
| Address 2: | Suite 110 |
| State: | MN |
| City / Town: | Minneapolis |
| Country: | USA |
| Postal Code: | 55447 |
| Exchange: | OTO |
| CEO: | Gregory J. Fluet |
| Employees: | 61 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Gathering Data... Please wait Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.
| Website: | www.urologix.com |
| Email: | mhill@urologix.com |
| Main Phone: | +1 763 475-1400 |
| Address: | 14405 21st Avenue North |
| Address 2: | Suite 110 |
| State: | MN |
| City / Town: | Minneapolis |
| Country: | USA |
| Postal Code: | 55447 |
| Exchange: | OTO |
| CEO: | Gregory J. Fluet |
| Employees: | 61 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 0.007 | Change $ 0.0017 | Change % 32.08 | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open 0.007 | High 0.007 | Low 0.007 | Prev Close 0.0053 |
| Last Trade | Volume 8,000 | 52 Wk Hi 0.15 | 52 Wk Low 0.0012 |
| Market Cap 152,724 | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 21,817,726.00 | EPS (TTM) -0.23 | PE Ratio N/A | Exchange OTCPK |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| Gregory J. Fluet | 1,000 |
| Mitchell Dann | 1,000 |
| Mitchell Dann | 1,000 |
| Gregory J. Fluet | 1,000 |
| Lisa Ackermann | 1,000 |
| Gregory J. Fluet | 1,000 |
| Gregory J. Fluet | 1,000 |
| Gregory J. Fluet | 1,000 |
| Gregory J. Fluet | 1,000 |
| Gregory J. Fluet | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 1.5 | 1.5 | 1.5 | 1.5 |
| Low Target Price Estimate | 1.5 | 1.5 | 1.5 | 1.5 |
| Mean Target Price Estimate | 1.5 | 1.5 | 1.5 | 1.5 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 05/02/13 | 05/02/13 | 05/02/13 | 05/02/13 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2016-07-12 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2016-05-17 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2016-03-25 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2016-02-23 |
| SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% | 1 | 2016-02-05 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2016-02-01 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2015-11-04 |
| 15-12G | Certification of termination of registration of a class of security under Section 12(g) or notice of suspension of duty to file reports under Section 13 and 15(d) of the Act Section 12 (g). | 1 | 2015-07-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2015-07-10 |
| SC 13D/A | Amendment to a SC 13D filing | 1 | 2015-07-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 2 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
